Hovione Acquires ExtremoChem

Barentz Acquires Viachem

October 6, 2022

Logistics & Distribution

Barentz International has acquired Viachem, a Plano, Texas–based specialty distributor of life science ingredients, specialty chemicals and food additives. Barentz said Viachem’s market development function, digital marketing and technical sales capabilities will be combined with Barentz’s global scale and infrastructure to accelerate market share growth in North America.

Primient Acquires Primient Covation

January 14, 2026

Manufacturing

Primient has acquired full ownership of Primient Covation, the producer of Susterra® and Zemea® 1,3-propanediols. Terms were not disclosed; the acquisition integrates Primient Covation's plant-based diols into Primient's sustainable ingredients portfolio to expand capability and market offerings. The move is intended to generate operational synergies and accelerate development and scale-up of sustainable bio-based materials.

H.B. Fuller Acquires Adhezion Biomedical and XCHEM International

June 22, 2023

Manufacturing

H.B. Fuller Company completed two strategic acquisitions: Adhezion Biomedical, a U.S. medical adhesives business, and XCHEM International, a UAE-based specialty adhesives and coatings manufacturer. The deals expand H.B. Fuller’s capabilities in medical/topical skin-bonding adhesives and establish its first manufacturing presence outside the U.S. for its Construction Adhesives (CA) business, contributing an estimated $17 million in revenue and $2 million in adjusted EBITDA for fiscal 2023.

eMolecules Acquires Synple Chem AG

September 24, 2024

Biotechnology

eMolecules, a San Diego-based provider of a chemical compound search-and-fulfillment platform and a portfolio company of Avista Healthcare Partners, has acquired Synple Chem AG, an automated chemical synthesis systems and services provider headquartered near Zurich, Switzerland. The acquisition adds Synple's automation technology and a virtual compound library of more than 7 trillion tractable compounds to eMolecules' existing offering, expanding its capabilities as a one-stop shop for compound procurement, management and automation for drug discovery customers.

Sanofi to Acquire Vicebio for Up to $1.6 Billion

July 25, 2025

Biotechnology

Sanofi will acquire clinical-stage biopharmaceutical company Vicebio in a deal worth up to $1.6 billion, including $1.15 billion upfront and $450 million in milestone payments. Vicebio, created by Medicxi using the University of Queensland's Molecular Clamp technology, develops multivalent vaccines targeting respiratory viruses and recently advanced a bivalent RSV/hMPV candidate into Phase 1 trials.

Evonik Industries Acquires PeroxyChem from One Equity Partners for $640 Million

February 3, 2020

Manufacturing

Evonik Industries AG has completed the acquisition of PeroxyChem, LLC, a global manufacturer of hydrogen peroxide and peracetic acid, from One Equity Partners for $640 million. The purchase, representing roughly a 9.9x multiple of EBITDA, expands Evonik's specialty chemicals portfolio and brings PeroxyChem's production footprint and technical capabilities into Evonik's global operations.